- 英文名称2-Bromo-1-(2,2-Dimethyl-4H-Benzo[d][1,3]Dioxin-6-yl)Ethanone
- 中文名称6-溴乙酰基-2,2-二甲基-4H-苯并[1,3]二噁英
- IUPAC名称2-bromo-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)ethan-1-one
- 其它别名2-溴-1-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)乙酮; 2-Bromo-1-(2,2-Dimethyl-4H-1,3-Benzodioxin-6-yl)-Ethanone
- CAS编号102293-80-1
- MFCD编号:MFCD26385854
- EINECS号:811-501-6
- 分子式:C12H13BrO3
- 分子量:285.13
- 产品CID: 50868
- 产品分类有机原料→分子砌块→芳杂环类化合物→其它芳杂环类化合物
相似化合物
54030-34-1 54030-33-0 71780-43-3欧盟法规
C&L通报上下游产品
CAS号116-11-0 2-甲氧基丙烯 | CAS号62932-94-9 2-溴-4'-羟基-3'-(羟... | CAS号77-76-9 2,2-二甲氧基丙烷 | CAS号24085-06-1 4-羟基-3-羟甲基苯乙酮二乙酸酯 | CAS号24085-07-2 2-乙酰氧基-5-(2-溴乙酰... | CAS号99-93-4 对羟基苯乙酮 | CAS号90-02-8 水杨醛 | CAS号115787-50-3 5-(2-溴乙酰基)-2-羟基苯甲醛 | CAS号452339-73-0 2-恶唑烷酮, 5-(2,2-...合成工艺路线路线简述
- 合成目标产物 2-Bromo-1-(2,2-Dimethyl-4H-Benzo[d][1,3]Dioxin-6-yl)Ethanone 主要起始原料 2,2-Dimethoxypropane And 2-Bromo-1-[4-Hydroxy-3-(Hydroxymethyl)Phenyl]Ethan-1-One
- (文献来源)合成步骤主要原料 2,2-Dimethoxypropane 和 2-Bromo-1-[4-Hydroxy-3-(Hydroxymethyl)Phenyl]Ethan-1-One
4-羟基-3-羟甲基苯乙酮二乙酸酯置于polyvinylpyridinium Bromide Perbromide Resin,Resin-So3H,氢溴酸体系中,用 四氢呋喃,二氯甲烷 用作溶剂,化学反应生成2-溴-1-(2,2-二甲基-4H-1,3-苯并二噁英-6-基)乙酮
参考文献:Synthesis Of The β2 Agonist (R)-Salmeterol Using A Sequence Of Supported Reagents And Scavenging Agents
标题:Synthesis Of The β2 Agonist (R)-Salmeterol Using A Sequence Of Supported Reagents And Scavenging Agents
摘要:Graphicthe Enantioselective Synthesis Of (R)-Salmeterol Has Been Achieved By Using A Sequence Of Supported Reagents And Sequestering Agents. The Saligenin Core Was Installed By A Regiospecific Alkylation And A Chiral Auxiliary Approach Was Employed To Introduce The Desired Stereochemistry Via A Diastereoselective Reduction.
Doi:10.1021/ol020128G
专利信息
专利号:WO-2023097678-A1
优先权日:2021-12-03
标 题:Method for synthesizing (r)-5-(2,2-dimethyl-4h-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one
发明人:ZHOU ZHANGTAO; YE WEIPING; PHILLIS ANDREW TOROA; XU LI; HUANG ZHINING; FU LI
权利人:GUANGDONG RAFFLES PHARMATECH CO LTD
摘要:A method for synthesizing (R)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one. The synthesis route of the method is: where X is Br, Cl or I, preferably Br. Preferably, chiral phenyloxazolidin-2-one is prepared from a 2-bromoacetophenone compound in a high-selectivity manner by means of protection, nucleophilic attack, asymmetric transfer hydrogenation, and finally CDI ring closing.